Valuation: DocMorris AG

Market Cap 50Cr 63Cr 54Cr 46Cr 87Cr 6.02TCr 89Cr 595.76Cr 233.29Cr 3.02TCr 236.68Cr 231.53Cr 9.99TCr P/E 2026 *
-6.38x
P/E 2027 * -12.8x
Enterprise Value 70Cr 88Cr 75Cr 65Cr 121.63Cr 8.41TCr 123.63Cr 831.86Cr 325.74Cr 4.22TCr 330.47Cr 323.28Cr 14TCr EV / Sales 2026 *
0.57x
EV / Sales 2027 * 0.53x
Free-Float
65.15%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 61 28/04/2022
Director of Finance/CFO 56 01/10/2024
Chief Tech/Sci/R&D Officer - 01/11/2024
Director TitleAgeSince
Chairman 68 28/04/2022
Director/Board Member 53 23/05/2019
Director/Board Member 56 01/01/2021
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00% - - 63Cr
-0.93%-2.43%-39.42%-6.63% 1.58TCr
+0.61%-1.21%-38.67%-23.48% 671.07Cr
+1.55%+2.65%-19.24%-13.17% 625.59Cr
-0.13%-0.25%-0.37%-24.31% 431.7Cr
+0.54%-2.20%-18.14%-39.59% 321.99Cr
0.00%-1.27%+4.49%-36.71% 302.99Cr
-0.53%-1.02%-44.71%-23.33% 302.51Cr
-0.09%-0.82%-12.17%-4.23% 262.61Cr
-0.81%-1.58%+49.49% - 240.51Cr
Average -8.81%-1.11%-13.19%-21.43% 526.82Cr
Weighted average by Cap. -1.22%-0.76%-23.16%-17.11%

Financials

2026 *2027 *
Net sales 123.68Cr 154.41Cr 132.45Cr 113.47Cr 213.38Cr 15TCr 216.9Cr 1.46TCr 571.46Cr 7.4TCr 579.77Cr 567.16Cr 24TCr 138.89Cr 173.4Cr 148.74Cr 127.43Cr 239.63Cr 17TCr 243.57Cr 1.64TCr 641.75Cr 8.31TCr 651.08Cr 636.91Cr 27TCr
Net income -8.1Cr -10Cr -8.68Cr -7.43Cr -14Cr -966.65Cr -14Cr -96Cr -37Cr -484.81Cr -38Cr -37Cr -1.6TCr -4.37Cr -5.45Cr -4.68Cr -4.01Cr -7.54Cr -521.18Cr -7.66Cr -52Cr -20Cr -261.39Cr -20Cr -20Cr -864.24Cr
Net Debt 20Cr 25Cr 21Cr 18Cr 35Cr 2.39TCr 35Cr 236.1Cr 92Cr 1.2TCr 94Cr 92Cr 3.96TCr 24Cr 29Cr 25Cr 22Cr 41Cr 2.82TCr 41Cr 278.43Cr 109.03Cr 1.41TCr 110.61Cr 108.21Cr 4.67TCr
Logo DocMorris AG
DocMorris AG, formerly Zur Rose Group AG, is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. DocMorris operates at the healthcare, technology and e-commerce, with a primary focus on customer-centric digital healthcare and improving medication efficacy. core business is online pharmacy. In addition to prescription medicines (Rx), assortment features over-the-counter (OTC) and consumer health as well as beauty and personal care (BPC) products. Private labels, including nutritional supplements, painkillers, first-aid products and other OTC medicines. The Company's operates under brands such as PromoFarma, DoctiPharma, Apotal, Medpex and Teleclinic, among others
Employees
-
Trader
Investor
-
Global
-
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
10.00CHF
Average target price
10.22CHF
Spread / Average Target
+2.19%

Quarterly revenue - Rate of surprise